BioPharmSignal logoBioPharmSignal

Biotech News

Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine

Xtant Medical (XTNT)Xtant MedicalCompany update

BELGRADE, Mont. , Dec. 1, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that the company has completed its previously announced sale of certain

Related news

XTNTXtant Medical2026-08-11 11:00 EST

Xtant Medical Reports Second Quarter 2026 Financial Results

XTNTXtant Medical2026-08-06 12:00 EST

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

ADPTAdaptive Biotechnologies2026-06-15 20:10 EST

Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses

TCMDTactile Systems Technology, Inc.2026-07-13 12:00 EST

Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients

STXSStereotaxis2026-07-09 12:08 EST

Stereotaxis Completes Acquisition of Robocath

SGHTSight Sciences2026-08-19 11:05 EST

TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease

STIMNeuronetics2026-08-11 11:50 EST

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

CVRXCVRx2026-08-06 20:05 EST

CVRx Reports Second Quarter 2026 Financial and Operating Results

PLSEPulse Biosciences2026-08-06 20:05 EST

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

SGHTSight Sciences2026-08-05 20:04 EST

Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems

View all latest news

Xtant Medical

Orthopedic Surgical Products Company Xtant Medical develops and distributes surgical products for spinal and other orthopedic procedures. Biologics and Implants The portfolio includes bone grafts, biologic materials, spinal fixation systems, and related surgical instruments. Hemostasis Expansion An exclusive U.S. distribution agreement...

Recent company news

XTNTXtant Medical2026-08-11 11:00 EST

Xtant Medical Reports Second Quarter 2026 Financial Results

XTNTXtant Medical2026-08-06 12:00 EST

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

XTNTXtant Medical2026-08-04 20:05 EST

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

XTNTXtant Medical2026-05-13 11:00 EST

Xtant Medical Reports First Quarter 2026 Financial Results

XTNTXtant Medical2026-05-07 12:00 EST

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Stock data

Close
0.32 USD
Market cap
65.22M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States